Nateglinide for type 2 diabetes.
D000284:Administration, Oral; D003510:Cyclohexanes / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004244:Dizziness / Q000139:chemically induced; D006801:Humans; D008687:Metformin / Q000627:therapeutic use; D000077715:Nateglinide; D010649:Phenylalanine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*
D003510:Cyclohexanes; D000077715:Nateglinide; D010649:Phenylalanine; D008687:Metformin